Loughborough University
Loughborough, Leicestershire, LE11 3TU, United Kingdom
NCT Number: NCT03735186
The present study will investigate the effect of acute exercise on fasting and postprandial risk markers for coronary heart disease (CHD) in healthy male cigarette smokers and non-smokers.
Participants will complete two, 2-day trials in a random crossover design separated by an interval of at least 1 week. On day 1, participants will rest (control) or complete 60 minute of treadmill exercise at 60% of maximum oxygen uptake (exercise). On day 2, participants will rest and consume two high fat meals (breakfast and lunch) over an 8-h period during which 13 venous blood samples and nine blood pressure measurements will be taken at pre-determined intervals.
It is hypothesised that men who smoke cigarettes will exhibit impaired fasting and postprandial metabolic risk markers compared to non-smokers, but a single bout of exercise will be equally, if not more, efficacious for improving the CHD risk factor profile in smokers than non-smokers.
Looking for future studies?
Notify Me20 year–45 year
Male
Interventional
Not applicable
Loughborough, Leicestershire, LE11 3TU, United Kingdom
Cigarette smoking is a strong and independent risk factor for CHD and is associated with impaired postprandial metabolism. Previous studies suggest that postprandial metabolism and other risk markers for CHD can be improved with acute exercise in healthy non-smokers, but less is known about responses in cigarette smokers. Therefore, the present study will compare the effect of acute exercise on fasting and postprandial risk markers for CHD in healthy male cigarette smokers and non-smokers.
A total of 12 healthy male cigarette smokers and 12 healthy male non-smokers matched for age and body mass index will be recruited. Before the main experimental trials, participants will attend the laboratory for a preliminary visit to complete screening questionnaires and to undergo familiarisation, anthropometric measurements (stature, body mass, waist and hip circumference, body fat) and exercise testing to determine maximum oxygen uptake.
Participants will complete two, 2-day (08:00-17:00) experimental trials in a randomised cross over design: control and exercise. On day 1, participants will arrive at the laboratory at 08:00 having fasted overnight and a baseline fasting venous blood sample and blood pressure measurement will be taken. A high fat breakfast and lunch meal will be consumed at 08:30 and 12:00, respectively. The control and exercise trials will be identical, except a 60 min bout of treadmill exercise at 60% of maximum oxygen uptake will be performed at 14:30 in the exercise trial.
On day 2, participants will arrive at 08:00 having fasted overnight for 10 h and will rest in the laboratory until 17:00. Participants in the smokers group will be asked to stop smoking at 08:00. A high fat breakfast and lunch will be consumed at 09:00 and 13:00, respectively. Venous blood samples from a cannula will be collected in the fasted state and at 0.25, 0.5, 1, 2, 3, 4, 4.25, 4.5, 5, 6, 7 and 8 h after the breakfast meal. Resting arterial blood pressure will be measured in the fasted state and at hourly intervals thereafter.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The National Health Interview Survey (NHIS) definitions will be used to identify cigarette smokers and non-smokers (Link: NHIS Adult Tobacco Use):
The following questions will determine the eligibility and group allocation:
If the person answers YES to Q1 and YES to Q2 they are eligible for the study and will be allocated to the smokers group.
If the person answers NO to Q1 and NO to Q2 they are eligible for the study and will be allocated to the non-smokers group.
Individuals answering any other combination (YES, NO or NO, YES) will not be eligible to take part in the study.
Exclusion criteria
60 min treadmill exercise performed at 60% of maximum oxygen uptake.
Time frame: 8 hours (Plasma samples will be collected at 0 (fasted), 0.25, 0.5, 1, 2, 3, 4, 4.25, 4.5, 5, 6, 7, 8 hours)
Total area under the plasma triacylglycerol concentration versus time curve on day 2
Time frame: 8 hours (Plasma samples will be collected at 0 (fasted), 0.25, 0.5, 1, 2, 3, 4, 4.25, 4.5, 5, 6, 7, 8 hours)
Time-course of plasma glucose concentrations on day 2 of the exercise and control trials.
Time frame: 8 hours (Plasma samples will be collected at 0 (fasted), 0.5, 1, 3, 4, 4.5, 6, 8 hours)
Time-course of plasma insulin concentrations on day 2 of the exercise and control trials.
Time frame: Fasting (Plasma samples will be collected at 0 (fasted) hours)
Homeostasis model assessment of insulin resistance (HOMA-IR) on day 2 of the exercise and control trials using fasting glucose and insulin concentrations.
Time frame: 8 hours (Plasma samples will be collected at 0 (fasted), 0.5, 1, 3, 4, 4.5, 6, 8 hours)
Time-course of plasma non-esterified fatty acid concentrations on day 2 of the exercise and control trials.
Time frame: Fasting (Plasma samples will be collected at 0 (fasted) hours)
Circulating concentrations of plasma total cholesterol in the fasted state on day 2 of the exercise and control trials.
Time frame: Fasting (Plasma samples will be collected at 0 (fasted) hours)
Circulating concentrations of plasma high-density lipoprotein cholesterol in the fasted state on day 2 of the exercise and control trials.
Time frame: Fasting (Plasma samples will be collected at 0 (fasted) hours)
Circulating concentrations of plasma low-density lipoprotein cholesterol in the fasted state on day 2 of the exercise and control trials.
Time frame: 8 hours (Plasma samples will be collected at 0 (fasted), 2, 5, 8 hours)
Time-course of plasma C-reactive protein concentrations on day 2 of the exercise and control trials.
Time frame: 8 hours (Plasma samples will be collected at 0 (fasted), 2, 5, 8 hours)
Time-course of plasma interleukin-6 concentrations on day 2 of the exercise and control trials.
Time frame: 8 hours (Plasma samples will be collected at 0 (fasted), 2, 5, 8 hours)
Time-course of plasma interleukin-10 concentrations on day 2 of the exercise and control trials.
Time frame: 8 hours (Plasma samples will be collected at 0 (fasted), 2, 5, 8 hours)
Time-course of plasma tumor necrosis factor alpha concentrations on day 2 of the exercise and control trials.
Time frame: 8 hours (Plasma samples will be collected at 0 (fasted), 2, 5, 8 hours)
Time-course of plasma peroxiredoxin-4 concentrations on day 2 of the exercise and control trials.
Time frame: 8 hours (Plasma samples will be collected at 0 (fasted), 2, 5, 8 hours)
Time-course of plasma superoxide dismutase 3 concentrations on day 2 of the exercise and control trials.
Time frame: 8 hours (Blood pressure will be measured at 0 (fasted), 1, 2, 3, 4, 5, 6, 7, 8 hours)
Time-course of systolic and diastolic blood pressure on day 2 of the exercise and control trials.
Loughborough University
Other
Acute Exercise and Coronary Heart Disease Risk Markers in Healthy Male Smokers and Non-Smokers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07316400
Behavior, Cigarette Smoking
Malang, East Java, Indonesia
View Trial DetailsNCT04429568
Behavior, Blood Coagulation Disorders
San Francisco, California, United States
View Trial DetailsNCT01596556
Behavior, Cigarette Smoking
Tel-Hashomer Ramat-Gan, Israel
View Trial DetailsNCT04525755
Behavior, Cigarette Smoking
Charleston, South Carolina, United States
View Trial Details